Welcome to our dedicated page for Health In Tech SEC filings (Ticker: HIT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Health In Tech, Inc. (Nasdaq: HIT) files a range of reports and disclosures with the U.S. Securities and Exchange Commission as a Nasdaq-listed, Nevada-incorporated InsurTech platform company. Its SEC filings provide detailed information on financial performance, governance, equity plans, and material corporate events related to its AI-enabled healthcare and insurance marketplace.
On this page, you can review Health In Tech’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which discuss revenues, operating expenses, cash flows, and segment-related data for its insurance technology platform. These filings also describe risk factors, business strategy, and the company’s focus on process simplification and automation for insurers, brokers, and TPAs.
Health In Tech’s current reports on Form 8-K document specific events such as earnings announcements, investor presentations, stockholder meetings, equity incentive plan amendments, restricted stock awards tied to new initiatives and programs, and changes in executive roles. For example, 8-K filings describe the company’s annual meeting voting results, grants of restricted stock for new initiatives, and terminations or appointments of certain officers.
Investors interested in ownership and governance can use proxy materials such as the DEF 14A definitive proxy statement to understand board elections, equity plan proposals, auditor ratification, and voting structures for Class A and Class B common stock. These documents outline how Health In Tech manages compensation, board composition, and stockholder rights.
Stock Titan enhances access to these filings with AI-powered summaries that explain key points from lengthy documents, helping users quickly interpret complex sections of 10-Ks, 10-Qs, and 8-Ks. Real-time updates from EDGAR ensure that new filings for HIT appear promptly, while structured views of forms such as 8-K and proxy statements make it easier to track developments in Health In Tech’s InsurTech operations, capital structure, and governance over time.
Health In Tech, Inc. is registering 5,600,000 shares of Class A Common Stock for resale by selling stockholders under a shelf registration. The resale shares were issued in a PIPE and the company will receive no proceeds from secondary sales.
The registration covers shares issued in the PIPE Offering that closed on March 27, 2026 and is being filed pursuant to the related Registration Rights Agreement. The prospectus lists plan of distribution options and states shares may be sold on Nasdaq (symbol HIT) or by other permitted methods.
Health In Tech, Inc. director and Chief Executive Officer Tim Donald Johnson reported a tax-related share disposition. On April 15, 2026, he surrendered 35,140 shares of Class A Common Stock at $1.50 per share to cover withholding and remittance obligations triggered by the vesting of restricted stock.
After this tax-withholding disposition, he directly holds 23,514,601 Class A shares, consisting of 1,079,624 restricted and 22,434,977 unrestricted Class A shares, and this figure excludes 9,000,000 Class B shares and 734,707 stock options.
Health In Tech, Inc. Chief Growth Officer Hasan Zain Syed surrendered 3,448 shares of Class A Common Stock at a price of $1.50 per share to the company to cover tax withholding on vested restricted stock. Following this tax-withholding disposition, he directly holds 216,552 Class A shares, including 211,552 restricted shares and 5,000 unrestricted shares.
Health In Tech, Inc. director and Chief Financial Officer Qian LinLin reported a routine tax-related share disposition. On the vesting of previously granted restricted Class A Common Stock, 21,480 shares were surrendered to the company at $1.50 per share to satisfy tax withholding and remittance obligations, rather than sold on the open market.
After this tax-withholding disposition, LinLin directly holds 9,107,075 shares of Class A Common Stock, consisting of 1,086,284 restricted shares and 8,020,791 unrestricted shares, while separately excluding 2,700,000 shares of Class B Common Stock and 711,510 options to purchase Class A Common Stock.
Health In Tech, Inc. Chief Executive Officer and 10% owner Johnson Tim Donald reported a compensation-related share transaction. On the vesting of restricted Class A Common Stock, he surrendered 35,140 shares at $1.50 per share to the company to satisfy tax withholding obligations. This Form 4 characterizes the move as a tax-withholding disposition, not an open-market sale, and indicates he continues to hold a substantial direct position in Class A Common Stock after the transaction.
McStravock John reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. reported that General Counsel John McStravock received a grant of 5,000 restricted shares of Class A Common Stock as equity compensation. These shares were granted at no cash cost to him.
The restricted shares will vest in equal monthly installments over a twelve-month period starting on April 6, 2026, as long as he continues to serve with the company through each vesting date. After this grant, he holds 5,000 Class A shares directly.
Health In Tech, Inc. filed an initial insider ownership report for its General Counsel, John McStravock. This Form 3 lists him as an officer but shows no reported stock transactions or derivative positions and no holding entries at the time of this filing.
Shrestha Sanjay K reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Sanjay K. Shrestha received a grant of 13,598 restricted shares of Class A Common Stock, valued at $1.36 per share, as compensation under the Health in Tech Equity Incentive Plan. The restricted stock vested on the grant date, bringing his direct holdings to 82,333 shares.
Howard William D. reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Howard William D. received a grant of 13,598 restricted shares of Class A Common Stock, valued at $1.36 per share, as equity compensation under the Health in Tech Equity Incentive Plan. The restricted shares vested as of the grant date, and he now directly holds a total of 119,643 Class A Common shares.
Hayes Timothy reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Timothy Hayes received a grant of 13,598 restricted shares of Class A Common Stock on April 8, 2026 under the Health in Tech Equity Incentive Plan. The filing reports the transaction at $1.36 per share.
The footnote states these restricted shares vested as of the grant date, meaning they became fully owned immediately. Following this equity award, Hayes directly holds 119,643 shares of Class A Common Stock.